E2 ModeratePreliminaryPEM unclearCross-SectionalPeer-reviewedMachine draft
Chronic fatigue syndrome and impaired peripheral pulse characteristics on orthostasis--a new potential diagnostic biomarker.
Allen, John, Murray, Alan, Di Maria, Costanzo et al. · Physiological measurement · 2012 · DOI
Quick Summary
This study tested a new way to measure how the heart and blood vessels respond when people stand up, using a painless light-based sensor on the ears, fingers, and toes. Researchers found that people with ME/CFS had a weaker blood vessel response to standing compared to healthy controls, which could potentially be used as an objective test to help diagnose ME/CFS.
Why It Matters
ME/CFS currently lacks objective diagnostic biomarkers, forcing clinicians to rely on symptom reporting and exclusion criteria. This study demonstrates that non-invasive optical sensors can detect measurable cardiovascular dysfunction in ME/CFS patients, potentially providing an objective tool to aid diagnosis and validate the biological basis of the condition.
Observed Findings
- CFS patients showed significantly reduced overall pulse timing response to standing (26% median change vs 37% in controls, p=0.002).
- No significant differences in pulse amplitude measures were found between CFS and control groups at any site.
- Pulse amplitude changes showed weak but significant negative correlation with fatigue severity (p<0.05).
- ROC analysis of timing measures alone produced area under the curve of 0.81.
- Combined timing and amplitude measures via linear discriminant analysis achieved 82% overall diagnostic accuracy.
Inferred Conclusions
- Non-invasive photoplethysmography can detect objective cardiovascular pulse wave abnormalities in CFS patients that differ from healthy controls.
- Pulse transit time (timing) measures appear more discriminative than amplitude measures for differentiating CFS from controls.
- Pulse wave abnormalities represent a potential objective biomarker to help differentiate CFS patients from healthy individuals.
Remaining Questions
- Can this test reliably distinguish ME/CFS from other conditions causing orthostatic intolerance or autonomic dysfunction (e.g., POTS, long COVID, deconditioning)?
- Do pulse wave abnormalities persist longitudinally, or do they change with disease progression or treatment?
What This Study Does Not Prove
This study does not prove that pulse wave abnormalities cause ME/CFS or that the test can distinguish ME/CFS from other conditions causing orthostatic intolerance (such as POTS, deconditioning, or other autonomic disorders). The cross-sectional design cannot establish whether these cardiovascular changes persist over time or whether they improve with treatment.
Tags
Symptom:Orthostatic IntoleranceFatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →